What are the recommended laboratory tests for diagnosing pheochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Laboratory Tests for Diagnosing Pheochromocytoma

Plasma free metanephrines should be the first-line biochemical test for diagnosing pheochromocytoma due to their superior sensitivity (96-100%) and specificity (89-98%). 1, 2

Primary Diagnostic Tests

  • Plasma free metanephrines are the most sensitive (99%) and specific (89%) test for diagnosing pheochromocytoma and should be the initial test of choice 3, 2
  • For optimal results, plasma free metanephrines should be collected from an indwelling venous catheter after the patient has been lying supine for 30 minutes to minimize false positives 1
  • If plasma testing is equivocal (less than fourfold elevation), a follow-up 24-hour urine collection for catecholamines and metanephrines should be performed 4
  • Urinary fractionated metanephrines are an acceptable alternative with high sensitivity (86-97%) and specificity (86-95%) 1, 2

Interpretation of Results

  • Results greater than 4 times the upper limit of normal are highly suggestive of pheochromocytoma and warrant immediate imaging 1
  • Moderately elevated results (1-4 times upper limit of normal) may require repeat testing or additional confirmatory tests 1
  • False positive elevations are usually less than 4 times the upper limit of normal and can occur with obesity, obstructive sleep apnea, or use of tricyclic antidepressants 1

Confirmatory Testing

  • Clonidine suppression testing is recommended in cases of equivocal results with strong clinical suspicion, with 100% specificity and 96% sensitivity 1, 5
  • The test is considered negative if normetanephrine levels fall by more than 40% or to below the upper limit of normal after clonidine administration 5

Additional Testing

  • Plasma methoxytyramine measurement can help assess the likelihood of malignant disease 4, 3
  • After biochemical confirmation, abdominal CT or MRI should be performed for tumor localization 3
  • For patients with suspected metastatic disease, functional imaging may be indicated 4

Special Considerations

  • Testing should be considered in patients with:
    • Early-onset hypertension (<30 years) 1
    • Resistant hypertension 1
    • Paroxysmal hypertension with classic symptoms (headache, palpitations, sweating) 1
    • Significant blood pressure variability 1, 3
    • Family history of pheochromocytoma 1

Common Pitfalls

  • The average time from initial symptoms to final diagnosis is approximately 3 years, highlighting the importance of appropriate testing 3, 6
  • Many cases are missed during life, with 55% of deaths attributed to the tumor and 75% of cases not suspected before death 3
  • Approximately 35% of pheochromocytomas are hereditary, so genetic testing should be considered, especially in patients with family history, young age at diagnosis, bilateral tumors, or extra-adrenal location 3
  • Avoid misinterpreting mildly elevated results (less than 4 times upper limit of normal) as definitive evidence of pheochromocytoma without confirmatory testing 1, 5

Following this diagnostic algorithm will optimize the detection of pheochromocytoma while minimizing false positive and false negative results, ultimately reducing morbidity and mortality associated with this condition.

References

Guideline

Diagnosis and Management of Pheochromocytoma in Hypertensive Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pheochromocytoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pheochromocytoma.

Journal of clinical hypertension (Greenwich, Conn.), 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.